Oncothyreon Inc. News Headlines

ONTY 
$2.71
*  
0.02
0.73%
Get ONTY Alerts
*Delayed - data as of Aug. 1, 2014 11:41 ET  -  Find a broker to begin trading ONTY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ONTY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Wednesday Sector Leaders: Biotechnology, Paper & Forest Products
7/23/2014 2:24:17 PM - BNK Invest

Shortage Of R&D At Big Pharma Creates Demand For Small Biotech: Joseph Pantginis
6/6/2014 1:45:00 PM - Seeking Alpha

Oncothyreon To Present At Jefferies Global Conference; Webcast At 9:00 AM ET
6/4/2014 8:00:00 AM - RTT News

Oncothyreon Collaborates with Celldex - Analyst Blog
5/30/2014 4:40:00 PM - Zacks.com

Healthcare Stocks Climbing in Late Trade; Celldex, Oncothyreon Partnering on Prospective Cancer Treatment
5/29/2014 3:53:26 PM - MT Newswires

Sector Update: Healthcare
5/29/2014 3:52:18 PM - MT Newswires

As Investors Laud Combination Therapies, Oncothyreon's Pipeline Could Come Into Focus
4/24/2014 10:25:00 AM - Seeking Alpha

Merck KGaA Starts Study on Tecemotide - Analyst Blog
4/8/2014 6:55:01 PM - Zacks.com

Oncothyreon Inc. (ONTY) in Focus: Stock up 6.1% - Tale of the Tape
3/20/2014 8:44:01 AM - Zacks.com

Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape
3/6/2014 10:46:01 AM - Zacks.com

Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% - Tale of the Tape
2/26/2014 10:18:01 AM - Zacks.com

Oncothyreon Inc. (ONTY) in Focus: Stock Up 5.2% - Tale of the Tape
12/2/2013 9:44:01 AM - Zacks.com

Investments In Targeting HER2 For The Treatment Of Cancer
10/28/2013 10:39:00 AM - Seeking Alpha

Data on Oncothyreon's ONT-380 - Analyst Blog
10/8/2013 4:27:12 PM - Zacks.com

Merck Pushes On With Failed Cancer Vaccine
9/25/2013 12:54:00 PM - Seeking Alpha

US Futures Nearly Unchanged as Market Mulls Washington Budget, Debt Limit Risks
9/25/2013 9:05:57 AM - MT Newswires

Pre-Market Most Active for Sep 25, 2013 : MAKO, FB, ONTY, WR, RDS/A, BAC, CCL, BBRY, YHOO, ASNA, JCP, AU
9/25/2013 8:39:57 AM - NASDAQ.com News

US Futures Slightly Lower as Risk of Government Shutdown Looms
9/25/2013 8:36:09 AM - MT Newswires

Inovio's Partnership & It's Many Benefits
9/11/2013 10:15:00 AM - Seeking Alpha

Oncothyreon Starts Study on ONT-380 - Analyst Blog
9/4/2013 7:15:01 PM - Zacks.com

You Might Own Oncothyreon For All The Wrong Reasons
8/22/2013 9:08:00 AM - Seeking Alpha

6 Oncology-Focused Biotech Growth Engines: Mara Goldstein
8/2/2013 6:01:00 PM - Seeking Alpha

Array BioPharma, Celgene Collaborate - Analyst Blog
7/31/2013 5:21:12 PM - Zacks.com

Array - Loxo Collaborate - Analyst Blog
7/11/2013 6:57:08 PM - Zacks.com

Oncothyreon Might Be Worth It
6/20/2013 3:12:00 PM - Seeking Alpha